Built upon the combined strength and experience of Embrex and Pfizer, Pfizer Poultry Health (PPH) is committed to developing and commercializing novel therapeutic, mechanical, and data management products which continue to provide increasing value to the global poultry health industry.

Embrex’s reputation for reliable service, industry knowledge, and innovative device design is unsurpassed in the poultry industry. With the introduction of the Inovoject automated delivery system in 1993, Embrex revolutionized hatchery vaccination practices and rapidly established in ovo vaccination as the industry standard used to inoculate over 80% of the birds raised in North America.

Pfizer, the world’s largest research-based biomedical and pharmaceutical company, has over 150 years of experience in discovering, developing, and manufacturing healthcare products designed to prevent, treat, and cure diseases across a broad range of therapeutic areas. Pfizer Animal Health is recognized as the worldwide leader in animal health research with over 55 years of experience in developing innovative therapeutics specifically targeted for the livestock and companion animal markets.

Leveraging the financial strength and resources of Pfizer along with the industry knowledge and reputation of Embrex, Pfizer Poultry Health is uniquely positioned to meet the challenges of delivering comprehensive solutions to the global poultry health industry.

An impressive past and a promising future...